Monoclonal Antibodies to the Large Glycoproteins of Respiratory Syncytial Virus: Possible Evidence for Several Functional Antigenic Sites

References

1. Anderson L. J., Hierholzer J. C., Stone Y. O., Tsou C., Fernie B. F. 1986; Identification of epitopes on respiratory syncytial virus proteins by competitive binding immunoassay. Journal of Clinical Microbiology 23:475–478
   [Google Scholar]
2. Belshe R. B., Van Voris L. P., Mufson M. A. 1982; Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial. Journal of Infectious Diseases 145:311–319
   [Google Scholar]
3. Fazekas De St.GROTH S., Scheidegger D. 1980; Production of monoclonal antibodies: strategy and tactics. Journal of Immunological Methods 35:1–21
   [Google Scholar]
4. Fernie F. F., Cote P. J. Jr Gerin J. G. 1982; Classification of hybridomas to respiratory syncytial virus glycoproteins. Proceedings of the Society for Experimental Biology and Medicine 171:266–271
   [Google Scholar]
5. Gruber C., Levine S. 1985; Respiratory syncytial virus polypeptides. IV. The oligosaccharides of the glycoproteins. Journal of General Virology 66:417–432
   [Google Scholar]
6. Kim H. W., Canchola J. G., Brandt C. D., Pyles G., Chanock R. M., Jensen K., Parrott R. H. 1969; Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. American Journal of Epidemiology 89:422–434
   [Google Scholar]
7. Kim H. W., Arrobio J. O., Brandt C. D., Jeffries B. C., Pyle G., Reid J. L., Chanock R. M., Parrott R. H. 1973; Epidemiology of respiratory syncytial virus infection in Washington, D.C. I. Importance of the virus in different respiratory tract disease syndromes and temporal distribution of infection. American Journal of Epidemiology 98:216–225
   [Google Scholar]
8. Kingsbury D. W., Bratt M. A., Choppin P. W., Hanson R. P., Hosaka Y., Ter Meulen V., Norrby E., Plowright W., Rott R. 1978; Paramyxoviridae. Intervirology 10:137–152
   [Google Scholar]
9. Srinivasappa J., Saegusa J., Prabhakar B. S., Gentry M. K., Buchmeier M. J., Wiktor T. J., Koprowski H., Oldstone M. B. A. 1986; Molecular mimicry: frequency of reactivity of monoclonal antiviral antibodies with normal tissues. Journal of Virology 57:397–401
   [Google Scholar]
10. Stott E. J., Bew M. J., Taylor G., Jebbett J., Collins A. P. 1984; The characterization and uses of monoclonal antibodies to respiratory syncytial virus. Developments in Biological Standardization 57:237–244
    [Google Scholar]
11. Taniguchi K., Urasawa S., Urasawa T. 1985; Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses. Journal of General Virology 66:1045–1053
    [Google Scholar]
12. Ueba O. 1980; Purification and polypeptides of respiratory syncytial virus. Microbiology and Immunology 24:361–364
    [Google Scholar]
13. Walsh E. E., Hruska J. 1983; Monoclonal antibodies to respiratory syncytial virus proteins: identification of the fusion proteins. Journal of Virology 41:171–177
    [Google Scholar]
14. Walsh E. E., Schlesinger J. J., Brandriss M. W. 1984; Purification and characterization of GP90, one of the envelope glycoproteins of respiratory syncytial virus. Journal of General Virology 65:761–767
    [Google Scholar]
15. Walsh E. E., Cote P. J., Fernie B. F., Schlesinger J. J., Brandriss M. W. 1986; Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies. Journal of General Virology 67:505–513
    [Google Scholar]
16. Wunner W. H., Pringle C. R. 1976; Respiratory syncytial virus proteins. Virology 73:228–243
    [Google Scholar]